相关实验视频

Updated: May 15, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

系统性硬化症-间歇性肺病治疗临床试验的进展和未来前景

Marzieh Jamali^1,2, Rocio Bautista Sanchez¹, Prachi Agarwal³

¹Division of Rheumatology, Department of Medicine, University of Michigan Scleroderma Program, Ann Arbor, MI, USA.

Expert review of respiratory medicine

|April 8, 2025

概括

系统性硬化症相关的间歇性肺病 (SSc-ILD) 需要改进诊断和个性化治疗. 在生物标志物和新疗法方面的进步对于SSc-ILD中更好的患者结果至关重要.

科学领域:

肺部医学肺部医学
类风湿病学类风湿病学
免疫学免疫学免疫学

背景情况:

系统性硬化症相关的间歇性肺病 (SSc-ILD) 是系统性硬化症 (SSc) 的常见和严重并发症.
在SSc-ILD的管理中,有很大需要解决知识差距并指导临床实践.
本文重点介绍了SSc-ILD的当前理解和最近的进展.

研究的目的:

提供SSc-ILD诊断,风险分层和治疗的全面分析.
突出这一领域的新兴进展和未来的研究方向.
为了告知临床实践和改善患者的结果.

主要方法:

审查关于SSc-ILD诊断,风险分层和治疗的当前文献.
分析高分辨率计算机断层扫描 (HRCT) 和肺功能测试 (PFT) 的作用.
评估新兴生物标志物 (CCL18,KL-6,IL-6,CRP) 和新的治疗策略.

主要成果:

HRCT和PFT是关键的诊断工具,但为了提高预后精度,需要生物标志物.
目前的治疗方法包括免疫抑制剂和抗纤维素药物;组合疗法和先进的疗法显示出有前途.
临床试验设计的挑战需要适应性和平台方法来解决疾病异质性.

结论:

生物标志物,复合指数和个性化疗法对于改善SSc-ILD患者的治疗结果至关重要.
解决疾病异质性和提高治疗敏感性对于未来的研究至关重要.
持续的研究和创新的临床试验设计对于推进SSc-ILD管理至关重要.

关键词:

系统性硬化症系统性硬化症临床试验是指临床试验中的临床试验.免疫抑制是一种免疫抑制.间歇性肺病间歇性肺病管理的管理管理的管理.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.